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ABSTRACT OF THE MASTER THESIS 
 
Histomorphometric Analysis of Maxillary Sinus Grafts:  
A Randomized Controlled Study 
 
by 
Mina Nishimoto 
Master of Science, Advanced Education Program in Implant Dentistry 
Loma Linda University, June 2016 
Dr. Joseph Y. K. Kan, Chairperson 
 
The purpose of this clinical investigation was to evaluate and compare the degree 
of new bone formation through histomorphometric analysis following maxillary sinus 
grafts (MSG) using three different bone graft materials.  Thirty-one MSG were 
performed using a lateral window approach for patients who required implant placement 
in posterior maxilla.  Each sinus was randomly selected to receive one of three bone graft 
materials; Group A: anorganic bovine bone mineral (ABBM) [Bio-Oss®], Group B: 
anorganic equine bone mineral (AEBM) [Equimatrix®], or Group C: mineralized 
cancellous bone allograft (MCBA) [OSSIF-i sem™].  A total of 28 bone cores were 
obtained at a mean time of 9.1 months following MSG and used for the 
histomorphometric analysis.  The quality of bone was also estimated (Lekholm & Zarb 
1985) during biopsy using a trephine bur.   
Histologically, newly formed bone showed close contact to the residual graft 
materials and interconnected the bone particles in all groups.  Histomorphometric 
analysis revealed statistically significant differences in the percentage of vital bone 
 xii 
(VB%) among three groups (Kruskal Wallis, P = .001).  The observed VB% was 
significantly lower [P= .004] in Group A (10.9 ± 8.9%) and also lower [P = .001] in 
Group B (9.1 ± 5.9%) as compared to Group C (32.0 ± 12.4%).  No significant difference 
in VB% was noted between Group A and Group B [P = 1.0].  
Within the confines of this study, a statistically significant difference in new bone 
formation was noted among the three graft materials at a mean follow-up period of 9.1 
months following MSG.  The MCBA (OSSIF-i sem™) group revealed significantly 
greater new bone formation when compared to the ABBM (Bio-Oss®) and AEBM 
(Equimatrix®) groups.  The AEBM showed comparable histomorphometric results in all 
parameters (VB%, RBM%, CT) when compared to ABBM.  Bone quality was greater in 
ABBA and AEBM groups in comparison to the MCBA group indicating the greater 
VB% does not directly translate to improved bone quality.  
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CHAPTER ONE 
INTRODUCTION 
   
 Maxillary sinus grafts (MSG) is a common and predictable procedure used to 
increase bone height for implant placement in the posterior maxilla and numerous bone 
graft materials have been advocated and used for the MSG (Jensen et al. 1998; Wallace & 
Froum 2003; Pjetursson et al. 2008; Del Fabbro et al. 2013).  The viability of these graft 
materials are often defined via histomorphometric analysis.    
 Boyne and James first described MSG using autogenous bone harvested from the 
iliac crest (Boyne & James 1980).  Since then, autogenous bone was considered as the 
“gold standard” for MSG due to its osteogenic potential (Moy et al. 1993; Lorenzetti et 
al. 1998; Hallman et al. 2002; Crespi et al. 2007).  Unfortunately, procuring autogenous 
bone from various sites (chin, ramus, iliac crest, calvaria) can possibly increase the risk 
of morbidity and discomfort (Kalk et al. 1996; Johansson et al. 2001; Nkenke et al. 2001, 
2004).  Because of that, non-autogenous bone graft materials (xenogarft, allograft and 
alloplast) have been suggested for MSG procedures (Smiler & Holms 1987; Smiler et al. 
1992; Boyne 1993; Moy et al. 1993; Wallace et al. 1996; Wheeler 1997; Valentini et al. 
1998; Scher et al. 1999; van den Bergh et al. 2000).  
 Xenograft is the most frequently evaluated non-autogenous bone graft material for 
MSG and anorganic bovine bone material (ABBM) [Bio-Oss®, Geistlich, Princeton, NJ] 
is the most studied xenograft material (Piattelli et al. 1999; Valentini et al. 2000; Wallace 
et al. 2005; Cordaro et al. 2008; Testori et al. 2013).  Implant has shown high success in 
xenograft despite of its osteoconductive property (Aghaloo & Moy 2007; Jensen et al 
2012).  Another xenograft material, anorganic equine bone mineral (AEBM) has been 
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recently introduced (Arteste et al. 2011; Nevins et al. 2013; Di Stefano et al. 2015, 2016).  
A multicenter case series found the percentage of vital bone after the healing of AEBM 
(Equimatrix®, Osteohealth, Shirley, NY) in MSG seemed to be comparable that of 
ABBM (Nevins et al. 2013).  To date, there is limited information available with regard 
to AEBM or comparison studies between AEBM and ABBM.   
 Allograft is another bone graft material used for MSG (Scher et al. 1999; van den 
Bergh et al. 2000; Noumbissi et al. 2005; Froum et al. 2006; Soardi et al. 2011; Kolerman 
et al. 2012).  The osseoinductive nature of allograft may promote new bone formation.  
Froum et al. (2006) compared the efficacy of allograft (MCBA)(Puros®) to xenograft 
(ABBM)(Bio-Oss®) in new bone formation in MSG, found significantly greater vital 
bone in MCBA group as compared to the ABBM group (Froum et al. 2006).   
The purpose of this randomized clinical investigation was to compare new bone 
formation using histomorphometric analysis of two xenograft [ABBM (Bio-Oss®), 
AEBM (Equimatrix®)] and, one allograft MCBA (OSSIF-i sem™) material following 
MSG.  The null hypothesis was that there was no histomorphometric difference in new 
bone formation among the groups. 
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CHAPTER TWO 
MATERIAL AND METHODS 
Patient Selection 
This prospective clinical randomized controlled study was approved by the 
Institutional Review Board (IRB) of Loma Linda University (IRB #5130213) and was 
conducted at the Center for Implant Dentistry, Loma Linda University, School of 
Dentistry, California.  Patients who required MSG prior to implant placement were 
invited to participate in this study if they met the following criteria.   
 
Inclusion Criteria 
1. Patients 18 years or older who are able to read and sign a written consent form.  
2. Patients who possess partially or completely edentulous posterior maxilla requiring 
MSG via lateral window approach (unilateral or bilateral) in preparation for implant 
placement.  
3. Patients who would be available for a period of approximately 8 months for follow-up 
appointments, biopsy, and subsequent implant placement.  
  
Exclusion Criteria 
1. Patients who presented with a medical history that would complicate surgical 
procedures and/or the outcome of the study such as history of head and neck radiation 
treatment, uncontrolled diabetes, uncontrolled hypertension, uncontrolled blood 
disorder, alcohol or drug dependency, immunodeficiency diseases or any other 
medical and psychological conditions.  
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2. Signs or symptoms of maxillary sinus disease.   
3. History of smoking.  
4. Pregnancy. 
5. Poor oral hygiene. 
 
Study Design and Treatment Groups 
Thirty maxillary sinuses were included and randomly allocated into three equal 
treatment groups (Group A, B or C; n = 10 each group) according to the graft material to 
be used.  The treatment groups are as follow;   
 Group A (Control): ABBM (Bio-Oss®, Geistlich, Princeton, NJ). 
 Group B (Test): AEBM (Equimatrix®, Osteohealth, Shirley, NY). 
 Group C (Test): MCBA (OSSIF-i sem™, Osteohealth, Shirley, NY.)   
Figure 1 shows a flowchart of the study.  
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Figure 1.  Study flowchart  
 
Informed Consent 
In accordance with the standards of conduct established by the IRB of Loma 
Linda University, participants were required to sign an informed consent.  The purpose 
and the nature of the study were explained to the patients and patients who met our 
inclusion criteria participated in the study.  Patients were required to read, understand, 
and sign the consent form before being enrolled in the study.   
 
 6 
Randomization 
Randomization was performed by one investigator (MN) using Research 
Randomizer (Version 4.0) software (Geoffrey C. Urbaniak and Scott Plous; 
http://www.randomizer.org) at the time of enrollment in the study.  In event of a bilateral 
MSG, each maxillary sinus was randomly assigned different treatment groups.  
 
Patient and Site Withdrawal and/or Replacement  
A maxillary sinus was removed from the study and replaced if:  
1. Perforation of the maxillary sinus membrane equal to or greater than 5 mm in diameter 
was observed during the sinus surgery,  
2. Infection was noted during the healing phase after the surgery.  
If a patient was unable to attend the designated post-operative follow-up 
appointments or was uncooperative, the patient and the corresponding sinus(es) was 
dismissed from the study. 
 
Clinical Procedures 
Diagnosis and Treatment plan 
1. Preliminary impressions were made using a polyvinylsiloxane impression material 
(Exafast, GC America Inc., Alsip, IL) and the corresponding diagnostic casts were 
fabricated using a type III dental stone (Microstone, Whip Mix, Louisville, KY).  
2. Diagnostic casts were articulated using a face-bow transfer to a Panadent semi-
adjustable articulator (Panadent Corporation, Colton, CA).  An interocclusal record 
was made using either wax occlusion rim(s) and/or polyvinylsiloxane (Exabite, GC 
America Inc., Alsip, IL). 
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3. Diagnostic waxing of the missing teeth was made using a tooth-color wax (Pro-Art, 
Ivoclar Vivadent, Inc., Williams, Amherst, NY) and then duplicated with a type III 
dental stone for partially edentulous patients.  Conventional dentures were fabricated 
for the completely edentulous patients using conventional techniques.  A silicone 
index of the denture setup was created using condensation silicone lab putty 
(Polysiloxane Coltene Lab-Putty, Coltene Whaledent Inc. Cuyahoga Falls, OH). 
4. A vacuum-formed radiographic template (Polypropylene Coping Sheet, Ultradent 
Products, South Jordan, UT) with auto-polymerizing acrylic resin (Jet, radiopaque 
teeth color, Lang Dental, Wheeling, IL) was created using the duplicated cast in 
partially edentulous patients.  A radiographic template for completely edentulous 
patients was duplicated from the silicone index.  Radiopaque color auto-polymerizing 
acrylic resin was used for teeth and clear color was used for the base.  
5. All patients underwent a cone-beam computed tomography (CBCT) scan (i-CAT™ 
Cone Beam 3-D Imaging System, Imaging Sciences International, Inc. Hatfield, PA) 
was taken with the radiographic template in place. 
6. An additional template was fabricated for each patient using the same duplicated cast 
or silicone index.  These templates were indexed using groove(s) to locate the 
proposed biopsy site on lateral window.  All templates were fabricated by one of 
investigators (MN) (Figure. 4). 
 
Preoperative Procedures 
At the pre-surgical appointment, the patient’s vital signs (blood pressure and pulse 
rate) were recorded and medical history was updated.  Patients were given the following 
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choices of anesthesia for the MSG surgery: 
a) Local anesthesia (LA) only  
b) LA in conjunction with oral sedation (Halcion 0.25mg, Roxane Laboratories Inc., 
Columbus, OH) 
c) LA in conjunction with intravenous sedation  
One patient chose intravenous sedation and had a pre-surgical interview with the 
anesthesiologist who conducted sedation at the time of the surgery.  Seven patients opted 
for oral sedation.  The remaining 13 patients chose to undergo the procedure using only 
LA. 
Patients were questioned regarding drug allergy and prescribed appropriate 
antibiotics.  None of the enrolled patients reported drug allergy and were prescribed 
Amoxicillin 500 mg (TEVA Pharmaceuticals USA, Sellersville, PA) for prophylaxis 
using 2 g amoxicillin 1 hour prior to the surgery and continuing 500 mg three times a day 
post surgically for 7 days.  An analgesic (Ibuprofen 800 mg, American Health Packaging, 
Columbus, OH) was prescribed and the patient was instructed to take one tablet every 6 
hours as needed with a maximum dosage of 3200 mg per day.  To keep the surgical site 
clean, patients were instructed to rinse with 0.12% chlorhexidine gluconate solution 
(Peridex, Zila Pharmaceuticals Inc., Phoenix, AZ) twice a day, 3 days before the surgery 
and 2 weeks after the surgery.  
 
Surgical Procedures 
Residents who had been calibrated prior the performed maxillary sinus graft 
surgeries under the direct supervision of the principal investigator (JK).  The principle 
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investigator reviewed the surgical approach prior to the surgery with all surgeons to 
ensure that there would be minimal variation between procedures.   
Treatment sequence:     
1. On the day of surgery, the patient was asked to rinse with a 0.12% chlorhexidine 
gluconate solution (Peridex) for one minute.  After being seated, a blood pressure cuff 
and pulse oximeter was placed to monitor the patient’s vitals during the surgery.  The 
circumoral area was scrubbed with a povidone-iodine swab stick (Aplicare, Aplicare 
Inc., Branford, CT) and the patient was draped.  Oxygen was administered to the 
patient using a nasal cannula at a rate of 3 liters/minute. 
2. After establishing anesthesia, a mid-crestal incision and with two vertical incisions 
were made anteriorly and posteriorly at the appropriate location to allow enough 
visualization and access.  A full-thickness mucoperiosteal flap was reflected to expose 
the lateral maxillary sinus wall.  
3. A lateral window was first outlined using a sterile pencil to make sure the size is wide 
enough for further biopsy.  The MSG would be performed via the lateral window 
approach either by removing the window completely using a dome shaped surgical 
diamond coated drill (DASK Drill #5; Dentium Advanced Sinus Kit, Dentium, Korea) 
or by outlining the proposed window with a slow speed carbide round bur (KOMET 
USA, Rock Hill, SC) and in-fracturing the lateral bone wall. 
4. The lateral window was positioned approximately 3 mm from the maxillary sinus 
floor and 3 mm from the anterior wall of the maxillary sinus to allow the sinus curettes 
to reach the maxillary sinus floor and the anterior wall.  The superior border was made 
approximately 15 mm higher from the alveolar crest to secure adequate amount of 
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graft for further biopsy (Figure 6).  The posterior border of the window was made at 
the right distal to the last implant planned.  
5. The maxillary sinus membrane was carefully elevated to create space for the bone 
graft.  The integrity of the maxillary sinus membrane was inspected visually its 
integrity confirmed using the Valsalva maneuver.  In the event of a perforation, the 
surgeon was instructed to proceed until the lateral window was complete and the 
appropriate displacement and reflection of the maxillary sinus membrane had been 
achieved.  A perforation (< 5 mm in diameter) was repaired by means of a resorbable 
collagen membrane (Bio-Gide®, Geistlich Pharma North America Inc., Princeton, NJ) 
placing over the perforation with at least 3 mm overlaying unaffected membrane in all 
directions.  Grafting procedure was continued following the repair.  Any perforation 
equal to or greater than 5 mm was excluded from the study.   
6. The inferior and superior border of the window were measured using the patient’s 
indexed template along the groove(s) with a periodontal probe (Pearson Color-Coded 
Probe CP15UNC, Pearson Dental Supply Company, Sylmar, CA, or #12, South 
Dakota, Single End, Yellow, American Eagle Instruments, Missoula, MT).  This 
would serve as the reference to locate the position of future biopsy site (Figure 4, 5, 6).  
The mesiodistal width of the lateral window was also measured.  
7. Bone graft materials; ABBM (Small granules Cancellous, 0.25-1.0 mm), AEBM 
(Cancellous, Particle Size 0.2-1.0 mm), or MCBA (Small particles, 0.25-1.0 mm) were 
placed into a maxillary sinus compartment for each respective group (Figure 7, 8, 9).  
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8. A resorbable collagen membrane (Bio-Gide®) was measured, trimmed, and placed 
over the graft material to ensure that membrane would extend approximately 3 mm 
beyond the borders of the lateral window. 
9. Flaps were approximated and primary closure was achieved using an expanded 
polytetrafluoroethylene (Gore-Tex, W.L. Gore and Associates, Inc. Newark, DE) 
suture for the crestal incision and coated polyglactin 910 suture (VICRYL® 6-0, 
Ethicon, Johnson & Johnson, Somerville, NJ) for the vertical incisions.  
 
        
Figure 2. Pre-operative view in Group A 
 
 
Figure 3. Complete removal of the lateral 
sinus bone wall. Checking the integrity of 
maxillary sinus membrane visually and by 
Valsalva maneuver 
 
       
Figure 4. Indexed for partially edentulous 
site 
Figure 5. Measurement of the inferior border 
of the window with the aid of template    
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Figure 6. Measurement of the superior 
border of the window with the aid of 
template 
 
Figure 7. Graft material placement in 
Group A  (Bio-Oss®) 
 
     
Figure 8. Graft material placement in 
Group B (Equimatrix®) 
Figure 9. Graft material placement in 
Group C (OSSIF-i sem™) 
 
 
Post-operative Instructions 
 Patients were advised to avoid blowing their nose, placing any undue pressure on 
the surgical site, and were instructed to maintain a liquid diet for two weeks after the 
surgery.  Following this two-week period, the patient was instructed to transition to a soft 
diet for one month and then continue to their general diet for the remainder of the healing 
phase.  Patients were instructed to follow the prescribed intervals for medications that 
were dispensed at the pre-operative appointment.  All removable prostheses were 
evaluated for proper tissue adaptation during the follow up period.  In cases with poor 
tissue adaptation, the prosthesis was modified and readapted using a soft reline material 
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(GC Reline Soft, GC, Alsip, IL).  Patients were scheduled two weeks following the 
surgery for suture removal and at 1, 3, and 6 months for subsequent follow up 
examinations.  
 
Surgical and Post-operative Complications 
Surgical and post-operative complications such as maxillary sinus membrane 
perforation, hemorrhage, wound opening, suppuration, acute or chronic graft infection 
and sinusitis were recorded. 
 
Biopsy Procedures 
1. A CBCT scan (i-CAT™, or NewTom VGi, NewTom, Verona, Italy) was taken two 
weeks prior to the biopsy and implant placement.  The same radiographic template 
was utilized to evaluate the grafted site and to determine the final implant position, 
implant size and the location of biopsy (Figure.10).  
2. Following a healing period of approximately 8 months, a full-thickness flap was 
reflected and the previous osteotomy site was located using the same template (Figure 
11, 12, 14, 16).  A trephine bur; 3.2 mm inner diameter, 4.0 mm outer diameter 
(Easyretrieve, ACE Surgical Supply Company, Inc., Brockton, MA) was used to 
collect a bone core with a minimum length of 8 mm within the previously prepared 
lateral window.  The quality of bone was estimated (Lekholm & Zarb 1985) during 
biopsy using the trephine bur.  The harvested bone core remained in the trephine bur 
was stored in 10% buffered formalin using a coded container (Figure 13, 15, 17).  The 
coded bone samples were sent to an outside laboratory (Hard Tissue Research 
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Laboratory, University of Minnesota School of Dentistry) for histologic and 
histomorphometric analysis. 
3. Post-operative care instructions were provided as previously described. 
     
 
     
Figure 10. Post-operative CBCT image 
 
              
Figure 11. Appearance of lateral window 
following 9 months of healing in Group A.  
Figure 12. Locating the area for biopsy 
using a periodontal probe and the 
template. 
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Figure 13. Bone core in a trephine (Bio-Oss®)  
 
       
Figure 14. Appearance of lateral window 
following 9 months of healing in Group B. 
Figure 15. Bone core in a trephine 
(Equimatrix®)
 
Figure 16. Appearance of lateral window 
following 9 months of healing in Group C  
 
Figure 17. Bone core in a trephine 
(OSSIF-i sem™) 
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Histology 
All 28 specimens were sent to the Hard Tissue Research Laboratory, University of 
Minnesota School of Dentistry for histomorphometric analysis.  Each specimen was 
numerically coded and stored in an individual container so that the patient’s information 
remained confidential and that examiners were blinded.  Non-decalcified histologic 
processing for histological evaluation was performed according to the method of Donath 
and Breuner (Donath & Breuner 1982; Rohrer MD, Schubert 1992).  The specimens were 
dehydrated with graded series of alcohols (Decon Labs, Inc. King of Prussia, PA) for 
approximately 3 - 4 weeks.  Following dehydration, the specimens were embedded in 
specialized Kulzer 7200 light polymerizing resin approximately for 10 hours (Technovit 
7200 VLC; Kulzer, Friedrichsdorf, Germany) and were cut in a longitudinal section 
through the center of the core to a thickness of 150 μm on an Exakt cutting/grinding 
system (Exakt Apparatebau, Norderstedt, Germany).  Following this, the samples were 
grinded and hand polished to a thickness of 45-50 µm using the Exakt microgrinding 
system, and they were stained with Stevenel’s blue and Van Gieson picro fuchsin.  Two 
slides were made from each of the specimens unless there are extenuating circumstances 
for a specific specimen making it possible to only produce one acceptable slide.  The 
percentages of vital, non-vital bone and non-bone components were quantified using 
computerized image analysis. 
 Vital bone stains bright red with variations in intensity depending on the maturity 
of the bone 
 Non-vital bone and osteoid stain bright green 
 Nuclei of cells, including osteoblasts, osteoclasts and osteocytes, stain blue. 
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 Connective tissue stains various shades of green. 
 Non-biologic materials such as ceramic material, hydroxyapatite, membranes, 
etc., are not affected by the stain and are easily visualized and analyzed. 
 
Histomorphometric Analysis 
All specimens were digitized at the same magnification using a NIKON ECLIPSE 
50i microscope (Nikon corporation, JAPAN) and a SPOT INSIGHT 2 mega sample 
digital camera (Diagnostic instruments Inc, USA).  Histomorphometric measurements 
were completed using a combination of SPOT 5.1 Advanced Software (Diagnostic 
instruments Inc, USA) and Adobe PhotoShop (Adobe Systems, Inc., San Jose, CA).  The 
measurements to be obtained and presented in tabular form are: 
1. Percentage of the area of the core, which is bone.  Of the bone, the percentage of vital 
and non-vital bone (Allograft). 
2. Percentage of non-bone material, which is the residual graft materials (Xenograft). 
3. Percentage of connective tissue and marrow. 
The histomorphometric data for each specimen was recorded as the average of the 
two slides from the specimen. 
 
Statistical Analysis 
Non-parametric, Kruskal-Wallis test was used to compare the percentage of vital 
bone formation (VB%), the percentage of residual graft material (RGM%) and the 
percentage of connective tissue/marrow (CT%) independently among three groups.  Post-
hoc comparisons were conducted with Dunn- Bonferroni pairwise tests.  The null 
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hypothesis for Kruskal-Wallis assumed no statistically significant difference in the 
amount of new bone formation.  All hypotheses tests were two-sided and tested at an 
alpha level of 0.05 using Statistical package for the social science (SPSS) version 22 
(SPSS®, IL). 
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CHAPTER THREE 
RESULTS 
Clinical Results  
Twenty-one patients with 31 maxillary sinuses were originally included in this 
study (Table 1).  Two patients with 3 sinuses were excluded during the course of the 
study.  Three sinuses (two patients) were excluded due to infection (sample A-6) and 
failure to comply with follow-up appointments (A-10 and B-9). 
A total of 19 patients (9 males and 10 females) with 28 sinuses (12 unilateral and 
8 bilateral) with a mean age of 61.5 (ranged 33 - 75) remained in the study (Table 1).  
One bone core was obtained from each sinus resulting in a total of 28 bone cores 
harvested for biopsy with a mean healing time of 9.1 months (ranged 7.6 - 12.3) (Table 
2).   
Type 2 and 3 bone was more commonly observed for Group A (8/9 88.8%) and 
Group B (7/9 77.8%), while Type 3 and 4 was observed in Group C (10/10 100%) during 
biopsy using the trephine bur (Table 3).  
Six maxillary sinus membrane perforations were encountered during surgery (A-
2, A-7, A-8, B-10, C-5, C-6) [21.4% (6/28)].  All sites were repaired with using 
resorbable collagen membranes (Bio-Gide) and the MSG procedures were completed 
without further complications (Table 2).  
One patient who underwent bilateral sinus grafts (B-7 and C-8) presented with 
suture breakdown resulting in two areas of approximately 3x15mm of granulation tissue 
two weeks following surgery.  No signs of infection were noted and complete wound 
closure was noted at the one-month follow-up (Table 2).  
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Table 1. Patient demographics and surgical site distribution 
* The sinus was excluded from the study due to infection 
** The sinus was excluded from study due to patient failure to comply with follow-up 
appointments 
Sample Number Gender Age Site 
Group A    
A-1 F 58 UR 
A-2 M 71 UL 
A-3 M 58 UL 
A-4 M 72 UL 
A-5 M 75 UR 
 A-6* F 63 UR 
A-7 F 66 UL 
A-8 F 33 UL 
A-9 F 55 UR 
     A-10 ** M 52 UL 
A-11  F 65 UR 
Group B    
B-1 M 61 UL 
B-2 M 58 UR 
B-3 M 72 UR 
B-4 M 69 UR 
B-5 F 54 UR 
B-6 F 65 UL 
B-7 M 70 UR 
B-8 M 72 UL 
    B-9 ** M 52 UR 
B-10 F 69 UL 
Group C    
C-1 F 35 UR 
C-2 F 55 UR 
C-3 M 29 UR 
C-4 M 75 UL 
C-5 F 63 UL 
C-6 M 69 UL 
C-7 F 54 UL 
C-8 M 70 UL 
C-9 F 69 UR 
C-10 M 60 UR 
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Table 2. Intraoperative and postoperative complications  
Sample Number 
Membrane 
Perforation 
Perforation size (mm) 
Postoperative 
complications 
Group A   
A-1 -    
A-2 Yes 2 x 3  
A-3 -   
A-4 -   
A-5 -   
  A-6* -  Infection (graft removal) 
A-7 Yes 1.5 x 1  
A-8 Yes  1 x 1  
A-9 -   
A-10 -   
A-11  -   
Group B    
B-1 -   
B-2 -   
B-3 -   
B-4 -   
B-5 -   
B-6 -   
B-7 -  Suture breakdown  
B-8 -   
B-9 -   
B-10 Yes 2 x 2  
Group C    
C-1 -   
C-2 -   
C-3 -   
C-4 -   
C-5 Yes 2 x 4  
C-6 Yes 3 x 5  
C-7 -   
C-8 -  Suture breakdown  
C-9 -   
C-10 -   
 * The sinus was excluded from the study due to infection 
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Table 3. Bone quality during biopsy at grafted sites 
Bone Quality Group A Group B Group C Total 
Type 1 0 0 0 0 
Type 2  3 1 0 4 
Type 3 5 6 5 16 
Type 4 1 2 5 8 
Classification of bone quality by Lekholm & Zarb (1985)  
 
Results: Histomorphometric Analysis  
All harvested cores were analyzed through histomorphometric analysis.  The 
mean healing time for the biopsy for Group A, B and C was 9.4 months (ranged 7.6 - 
11.3), 8.7 months (ranged 8.1 - 10.7), and 9.2 months (ranged 7.6 - 12.3), respectively 
(Table 4).  
Statistically significant differences were observed among all three groups in 
VB%, RBM%, and CT% [Kruskal Wallis, P = .001, P < .001, P = .028, respectively].   
Insignificant difference in VB% was noted between Group A (10.9 ± 8.9%) and 
Group B (9.1 ± 5.9%) [P = 1.0], but both were significantly less than Group C (32.0 ± 
12.4%) [P = .004; Group A, P = .001; Group B].  
No significant difference in RBM% was observed between Group A (34.3 ± 
12.1%) and Group B (38.9 ± 5.3%) [P = 1.0], but both were significantly higher than 
Group C (5.5 ± 5.7%) [P = .005; Group A, P = .003; Group B].   
Likewise, no significant difference in CT% was observed between Group A (54.8 
± 7.7%) and Group B (52.0 ± 6.1%) [P = 1.0], and Group A and Group C (62.5 ± 9.8%) 
[P = .179], but Group C was significantly higher than Group B [P = .031].  
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Table 4. Histomorphometric analysis of the three groups of graft materials 
Sample 
Number 
Healing Time 
(Months) 
Vital Bone 
Volume (%) 
Residual Graft 
Material (%) 
Connective Tissue / 
Marrow (%) 
Group A  
A-1   9.0   7.6    38.5  53.9 
A-2 11.3   8.1 44.7 46.9 
A-3   8.6 17.7 32.5 49.8 
A-4 10.7   5.1 35.8 59.1 
A-5   7.6   1.5 34.2 64.3 
A-7   8.3   0.1 43.7 56.2 
A-8 10.3 28.3   3.9 67.8 
A-9   8.4 14.0 39.0 47.0 
A-11  10.3 15.2 36.8 48.0 
Mean   9.4    
Group B     
B-1   7.9   2.4 35.6 62.0 
B-2   8.6 11.9 35.1 53.0 
B-3 10.7 10.2 38.3 51.5 
B-4   8.2   3.5 41.5 55.0 
B-5   9.2   7.2 38.2 54.6 
B-6   8.2 12.1 47.1 40.9 
B-7   9.0 14.7 31.0 54.3 
B-8   8.1   1.7 46.5 51.8 
B-10   8.6 18.6 36.4 45.0 
Mean    8.7    
Group C       
C-1   9.5 30.1  7.4 62.4 
C-2   8.4 28.1  6.0 65.9 
C-3 12.3 56.4     0 43.6 
C-4  7.6 34.3  6.4 59.3 
C-5  9.4 33.1 10.1 56.8 
C-6  8.2 22.4     0 77.6 
C-7  9.2 29.9  6.7 61.8 
C-8  9.0 30.1     0   69.9 
C-9  8.6 45.1     0   54.9 
C-10  9.3 10.0 17.3     72.7 
Mean  9.2    
Overall  9.1    
  
2
4
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Histomorphometric comparison of the percentage of vital bone, residual bone material and connective tissue/marrow 
among the groups  
a,b: different letters denote statistically significant difference using Dunn-Bonferroni pairwise tests at α = .05 
 
 Group A  Group B Group C P value 
 Mean ± SD  Mean ± SD  Mean ± SD   
VB% 10.9  ± 8.9a 9.1 ± 5.9a 32.0 ± 12.4b P = .001 
RBM% 34.3 ± 12.1a 38.9 ± 5.3a 5.5 ± 5.7b P < .001 
CT% 54.8 ± 7.7a.b  52.0 ± 6.1a 62.5 ± 9.8b P = .028 
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Results: Histologic Analysis 
Common findings among the three groups were follows: 1) specimens showed 
varying amounts of new bone formation and bone maturation; 2) areas of newly formed 
bone bridged well between residual bone graft particles.  This histologic observation 
demonstrated that all graft materials used in the study appeared to have osteoconductive 
properties. 
 
Group A 
Residual ABBM particles remained scattered in the field and easily 
distinguished from vital bone.  Newly formed bone interconnected particle to particle 
(Figure 18).  At high magnification, intimate contact was noted between the newly 
formed bone and the residual bone particles (Figure 19).  At very high magnification, 
osteoid was present along the new bone interface in some areas, indicating the process of 
new bone formation.  Osteoblasts were observed in the front line of the newly formed 
bone.  Abundant vascular structures, blood cells, and fibroblasts were observed in the 
connective tissue spaces (Figure 19, 20).  In one sample (A-7), fibrous tissue 
encapsulation of particles was observed in most of the field, which appeared to prevent 
from any new bone formation. 
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Figure 18.                   (Magnification ×25) 
 
Figure 19.                                       (×100) 
 
Figure 20.                                         (×200) 
 
Figure 18-20. Photomicrographs of ABBM. Newly formed bone (NB) interconnects bone 
particles (ABBM) throughout the filed.  Osteoblasts (arrow) and osteoid (OS) are 
observed in contiguity with the newly formed bone.  Abundant vascular structures are 
evident in the connective tissue space. (Stevenel’s blue and Van Gieson’s picro fuchsin 
stain).  
 
 
Group B 
The histological appearance of AEBM was similar to the one observed in ABBM 
(Figure. 21).  Residual bone particles were easily distinguishable from vital bone.  Newly 
formed bone was in close contact with the graft particles and interconnecting with 
various levels of bone maturation.  Lines of osteoblasts were observed at the interface of 
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the newly formed bone.  Abundant vascular structures were present in connective tissue 
spaces (Figure. 22, 23).  
              
Figure 21.                   (Magnification ×25)  
 
Figure 22.                                        (×100) 
 
Figure 23.                                        (×200) 
 
Figure 21-23. Photomicrographs of AEBM. Newly formed bone (NB) shows in direct 
contact to AEBM and interconnects residual bone particles similar to ABBM.  Osteoblast 
line (arrow), osteoid (OS), and vascular structures are seen. (Stevenel’s blue and Van 
Gieson’s picro fuchsin stain). 
 
 
Group C 
The MCBA demonstrated different histological findings from the previous two 
groups (Figure. 24).  Residual graft particles were bridged by vital bone with intimate 
 28 
contact (Figure. 25).  The bone particles were replaced with vital bone and was difficult 
to distinguish the residual bone particles from newly formed bone.  Osteoblasts were 
observed along with new bone formation (Figure. 26).  
        
Figure 24.                   (Magnification ×25) 
 
Figure 25.                                         (×100)
 
Figure 26.                                        (×200) 
 
Figure 24-26. Photomicrograph of MCBA. Newly formed bone (NB) is in intimate contact 
to MCBA and bridges residual bone particles as same as ABBM or AEBM.  Osteoblasts 
(arrow), osteoid (OS), and vascular structures are seen in the connective tissue (Stevenel’s 
blue and Van Gieson’s picro fuchsin). 
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CHAPTER FOUR 
DISCUSSION AND CONCLUSIONS 
Discussion 
One of the methods in evaluating the performance of a graft material for MSG is 
by histomorphometric analysis, which quantifies the percentage of vital bone formation 
after healing as well as the percentage of residual bone materials and connective 
tissue/marrow.  Nevertheless, numerous factors can affect the histomorphometric 
outcome of these graft materials following the MSG.  These factors are; graft materials 
used, location of bone core harvested, biopsy harvesting time, quality of grafted bone, 
presence of membrane to conceal the lateral sinus window, complications as well as 
operator experience. 
In this histomorphometric study, two xenograft materials (Group A {ABBM}, 
[Bio-Oss®], Group B, {AEBM}, [Equimatrix®]) and one allograft material (Group C 
{MCBA}, [OSSIF-i sem™]) were evaluated.  There is insignificant difference in the mean 
VB% between ABBM (10.9 ± 8.9%) and AEBM (9.1 ± 5.9%), but both were 
significantly less than MCBA (32.0 ± 12.4%) at a mean healing time of 9.1 months.  The 
VB% of allograft tends to out preform xenograft because of the greater graft turnover 
with allograft.  The mean VB% of ABBM (10.9%) and AEBM (9.1%) in this study is 
much lower, when compared to other studies evaluating the mean of VB% using ABBM 
[23.0% (0 - 53%)] and AEBM [23.4%]. (Yildirim et al. 2000; Wallace et al. 2005; Froum 
et al. 2006, 2013c; Lee et al. 2006; Mangano et al. 2007; Cordaro et al. 2008; Simunek et 
al. 2008; Choi et al. 2009; Chackartchi et al. 2011; Kolerman et al. 2012; Pettinicchio et 
al. 2012; Kao et al. 2012; Testori et al. 2013; Kohal et al. 2015) (Nevins et al. 2013).  On 
the other hand, the mean VB% for the MCBA in this study was similar to other studies 
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using allograft (Puros® and others) (29% [0 - 54.8%]) as a bone graft material 
(Noumbissi et al. 2005; Kolerman et al. 2008, 2012; Froum et al. 2006; Soardi et al. 
2011; Avil-Ortez et al. 2012).  It is interesting to note that, VB% of healed MSG tends to 
vary significantly regardless xenografts (0 - 53%) or allografts (0 - 54%).  In this study, 
the mean RBM% in ABBM (34.3 ± 12.1%) and AEBM (38.9 ± 5.3%) was significantly 
greater than the mean RBM% in MCBA (5.5 ± 5.7%).  This is because of the slow or 
non-turnover characteristics of xenograft when compared with allograft.  In fact, in a 
study in which bone core was harvested and evaluated at 6 months and 11 years after 
ABBM was used for MSG, ABBM particles were still observed at 11 years follow-up.  
Furthermore, the RBM% remained similar the two time frames (Mordenfeld et al. 2014).  
The mean CT% for ABBM (54.8 ± 7.7%), AEBM (52.0 ± 6.1%) and MCBA (62.5 ± 
9.8%) in this study is similarly high.  However, human native bone has been reported 
with similarly high CT% (47.2 - 75.5%) (Valentini et al. 2000; Galindo-Moreno et al. 
2009; Tosta et al. 2013). 
The two common locations to harvest biopsy cores for grafted maxillary sinus are 
either through the alveolar crest or the lateral window.  The VB% of cores harvested via 
lateral window in studies evaluated ABBM [20% (0 - 53%)] (Wallace et al. 2005; Froum 
et al. 2006, 2013c; Simunek et al. 2008; Choi et al. 2009; Kao et al. 2012; Testori et al. 
2013) as well as MCBA graft materials [25% (0 - 51%)] (Froum et al. 2006, 2013a) tend 
to be slightly less, when compared to the VB% in studies harvested via the alveolar crest 
using ABBM [26% (4.1 - 45.2%]) (Valentini et al. 2000; Yildirim et al. 2000; Lee et al. 
2006; Cordaro et al. 2008; Chackartchi et al. 2011; Kolerman et al. 2012; Pettinicchio et 
al. 2012; Di Stefano et al. 2015) as well as allograft (30% [0 - 54.8%]) (Noumbissi et al. 
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2005; Kolerman et al. 2008, 2012; Soardi et al. 2011; Avil-Ortez et al. 2012).  This is 
because the biopsy harvested from alveolar crest may include some native bone, which 
may lead to greater VB%.  Because of that, in this study, biopsy core was harvested from 
the lateral window.  
In this study, biopsy core were harvested approximately 8 months or more after 
MSG.  Hanisch et al., harvested biopsy cores from grafted maxillary sinus at 6, 8, 10, or 
12 months for histomorphometric analysis, reported the VB% was significantly greater at 
12 months as compared to at 6 or 8 months and the VB% increased up to 12 months 
(Hanisch et al. 1999).  Although there was a great ranged of biopsy harvesting time from 
7.6 to 12.3 months in this study, there was no statistically significant correlation between 
the overall biopsy harvesting time and the VB% in all groups; ABBA (7.6-11.3 months) 
[P =.330], AEBM (8.0-10.7 months) [P =.175] and MCBA (7.6-12.3 months) [P =.197].  
In this study, Type 2 and Type 3 bone were more commonly encountered during 
biopsy for ABBM and AEBM, while Type 3 and Type 4 bone were only encountered in 
MCBA (Table 3).  It is interesting to note the high VB% (32.0%) in MCBA did not 
translate into high drill resistance or high bone quality.  The greater drill resistance for 
ABBM and AEBM can be caused by the high RBM%.  In fact, residual bone graft 
particles in xenograft in grafted maxillary sinus can increase bone density thereby 
increasing drill resistance (Valentini et al. 2000).  
The need of resorbable membrane on the lateral window during MSG is 
controversial (Tarnow et al. 2000; Wallace & Froum 2003; Pjetursson et al. 2008; Garcia-
Denche et al. 2013; Suárez-López Del Amo et al. 2015).  Resorbable membrane has been 
shown to be effective in reducing connective tissue proliferation, though it has little 
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significant on new bone formation (Choi et al. 2009; Barone et al. 2013).  However, 
studies showed similar CT% when evaluated grafted maxillary sinus using ABBM (45% 
[24.7 - 74.7%]) (Yildirim et al. 2000; Wallace et al. 2005; Froum et al. 2006, 2013c; Lee 
et al.2006; Cordaro et al. 2008; Choi et al. 2009; Chackartchi et al. 2011; Kolerman et al. 
2012; Garcia-Denche et al. 2013; Testori et al. 2013; Kohal et al. 2015) when compared to 
ABBA without membrane (43% [33.0 - 78%]) (Valentini et al. 2000; Wallace et al. 2005; 
Mangano et al. 2007; Choi et al. 2009; Pettinicchio et al. 2012).  The mean CT% in 
studies using MCBA with membrane showed 56% [40 - 79%].  Despite the use of 
resorbable membrane, the CT% in this study in ABBM (54.8%) and MCBA (62.5%) was 
slightly higher than aforementioned studies.  Regardless, this is still with the range of the 
published CT% with membrane with xenografts (24.7 - 74.7%) or allografts (40 - 79%), 
as well as in human native bone (47.2 - 75.5%).  
 The rate of maxillary sinus membrane perforations was 6/28 (21.4%) in this 
study, which is similar to the rate (19.5%) reported in a systematic review by Pjetursson 
et al. (Pjetursson et al. 2008).  Although maxillary sinus membrane perforations can be 
associated with an increase in post-operative complications such as sinusitis, infection, 
and/or graft failure (Schwartz-Arad et al. 2004; Nolan et al. 2014), Froum et al. reported 
that properly repaired small to middle size perforation (<10 mm) did not have any 
adverse effect on vital bone formation (Froum et al. 2013b).  Similarly, the mean VB% 
(18.4%) does not seem to be compromised when small controlled perforations (< 5mm) 
were repaired with resorbable membrane in this study.  
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Conclusions  
Within the confines of this study, a statistically significant difference in new bone 
formation was noted among the three graft materials at a mean follow-up period of 9.1 
months following MSG.  The MCBA (OSSIF-i sem™) group revealed significantly 
greater new bone formation when compared to the ABBM (Bio-Oss®) and AEBM 
(Equimatrix®) groups.  The AEBM showed comparable histomorphometric results in all 
parameters (VB%, RBM%, CT) when compared to ABBM.  Bone quality was greater in 
ABBA and AEBM groups in comparison to the MCBA group indicating the greater 
VB% does not directly translate to improved bone quality.  
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